Sahil Khera is a Cardiology physician affiliated with Mount Sinai Health System. OpenAlex indexes 312 publications with 26,488 citations (h-index 39). By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1190 5th Ave
New York, NY 100296503
Telephone
212-427-1540Provider last certified this registry record 27 Mar 2026.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202542 payments$21,726openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202545 payments$20,114openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year202530 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.8%Calcium channel blocker17.5%Amlodipine Besylate100%Part D≥25 patientsBeta blocker16.8%Metoprolol Succinate45%Metoprolol Tartrate38%Carvedilol17%Part D<11 patients+ 8 more classes in this area
Blood & clotting
13.7%Factor Xa inhibitor8.5%Eliquis100%Part D≥21 patientsP2Y12 inhibitor5.2%Clopidogrel100%Part D≥13 patientsMetabolism & gastrointestinal
9.5%SGLT2 inhibitor6.9%Jardiance100%Part D<11 patientsProton pump inhibitor2.6%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis
Journal of the American College of Cardiology
2025 - First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
JACC: Cardiovascular Interventions
2023 - Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR)
JACC: Cardiovascular Interventions
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Desnick, PhD, MD
Mount Sinai Health System
Mathew Williams, MD
Mount Sinai Health System
Ashutosh Tewari, MD
Mount Sinai Health System
Thomas Schiano, MD
Mount Sinai Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”